InvestorsHub Logo

TheMonolith

08/22/17 11:00 AM

#271 RE: Traderfan #270

Got it - yeah not exactly a bean counting value play, but not expensive at all if you have vision. Of course, vision is not guaranteed.

zenvesting

08/23/17 12:37 PM

#273 RE: Traderfan #270

You are both right, COV.v is relatively highly valued when compared to other Canadian Venture exchange technology stocks, that trade mostly based on valuations irregardless of business fundamentals and outlook.

However, Covalon trades relatively cheaply when compared to it's peers in the advanced wound care and medical coatings markets, which mostly trade in the US and loose money like it didn't matter. ALQA, DSCI, MDWD, SRDX, and maybe MDXG if COV's project in that area ever gets some light shed on it.